Hunan high-value consumables two-vote system started

On July 4, a new round of management and control of consumables came to our province. On July 2, Hunan Provincial Health and Health Commission issued the document "Key Tasks for Deepening the Reform of Medical and Health System in 2019" (Hunan Medical Reform No. 1). The document clearly points out that the policy system of "two-ticket system" for drug purchase and sale should be improved. Strengthen the inspection of purchase and sale bills, and promote the interconnection of centralized procurement information of pharmaceutical consumables and data of tax system. To explore the "two-ticket system" for the purchase and sale of high-value medical consumables. The provincial health and health commission, provincial health insurance bureau, Hunan tax bureau of the State Administration of Taxation and provincial public resources trading center are jointly responsible for the implementation of the promotion. At the same time, we should improve the procurement, distribution and settlement management of drugs and consumables. Explore drug purchasing with quantity, Quantity-price linkage and price-for-quantity, so as to significantly reduce drug prices. We will strengthen the management of drug purchase and sale contracts and standardize the payment of drug payments. Explore and promote the "three streams in one" information management model of pharmaceutical procurement.

You can see that "three-in-one" is mentioned again. Medical reform has always followed the rule of "drugs first, instruments later". It is to unify information flow, business flow and capital flow. Public institutions, production enterprises and distribution enterprises will purchase and settle products online. Professionals have pointed out that the key to the implementation of "three-in-one" is the settlement link. The enterprises directly invoice the medical institutions, and the enterprises can receive the payment directly from the medical institutions, and then pay the logistics expenses of the commercial companies. The mode is to reduce the turnover and increase price of middlemen and weaken their functions. Nowadays, the collection and collection of consumables has become a matter of great concern in the industry. CITIC Securities has mentioned in a research paper that under the three-in-one mode, the concentration of the industry has increased significantly. From the perspective of the impact on the industrial chain, small enterprises exit quickly, thus indirectly realizing the "band quantity". Documents particularly emphasize that the high-value medical consumables with a relatively high proportion of unit price and resource consumption will be treated with emphasis. The provincial health and health commission, the provincial medical insurance bureau and the provincial drug regulatory bureau are responsible.

The direction of this governance is to implement the central policy. On May 29 this year, the Eighth Meeting of the Central Committee for Comprehensive and Deepening Reform was convened, at which the Reform Plan for the Control of High-value Medical Consumables was deliberated and adopted. The meeting pointed out that the management of high-value medical consumables has reduced the medical burden of the people. It is necessary to rationalize the price system of high-value medical consumables, improve the whole process supervision and management, purify the market environment and the medical service practice environment, and promote the formation of a management pattern of reliable quality, fast circulation, reasonable price and standardized use of high-value medical consumables, so as to promote the health of the industry. Sequential development. The governance of high-value consumables has become one of the key objectives of the new health care reform. Among them, price system, supervision and management, and purification of the environment become key words in the process of governance.

Although not mentioned in the document of Hunan Province, if enterprises do not strictly implement the punishment of the two-vote system. However, judging from the punishment measures in Fujian Province, the government is determined to promote the two-vote system for high-value consumables. In April of this year, Fujian Medical Insurance Bureau held a symposium on medical device circulation enterprises. As to when to implement the two-vote system in an all-round way, Fujian Medical Insurance Bureau said that the comprehensive situation would require hospitals to purchase on the platform and strictly check the two-vote system.

In response to the different recognition of the low value and high value of networking in hospitals, it pointed out that as long as the current networking belonged to high-value consumables, if the hospital did not purchase by platform distribution, it would occupy 5% of the target of purchasing for record, which was linked to the annual salary assessment of hospital presidents, and had a restrictive effect on hospitals. For those enterprises that do not cooperate with the implementation of the two-vote system, the information disclosed in the above-mentioned symposium is that the Medical Insurance Bureau will interview manufacturers. However, there is an exception, the response mentioned that for specific market behavior, we still need to act according to market rules, emphasizing the spirit of the contract.